OraSure Technologies, Inc. - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
OSUR Nasdaq 2835 http://www.orasure.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for OraSure Technologies, Inc.

Investors in OraSure Technologies (NASDAQ:OSUR) have unfortunately lost 74% over the last five years - Dec 21st, 2022 12:52 pm
OraSure Technologies Continues its Dedication to Ending the HIV Epidemic - Dec 1st, 2022 12:05 pm
OraSure Technologies to Present at Stephens Annual Investment Conference - Nov 14th, 2022 12:05 pm
OraSure Technologies (OSUR) Q3 Earnings and Revenues Top Estimates - Nov 8th, 2022 11:05 pm
OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year - Nov 8th, 2022 9:05 pm
OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA) - Nov 3rd, 2022 1:15 pm
InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store - Nov 2nd, 2022 11:05 am
2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET - Nov 1st, 2022 11:05 am
3 Penny Stocks That Are Too Cheap to Ignore - Oct 7th, 2022 1:14 pm
Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Deliver On Growth Plans? - Oct 1st, 2022 2:30 pm
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test - Sep 28th, 2022 2:28 pm
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test - Sep 28th, 2022 11:05 am
OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention - Sep 20th, 2022 8:05 pm
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health - Sep 14th, 2022 11:05 am
Independent Director Ronny Lancaster Just Bought 91% More Shares In OraSure Technologies, Inc. (NASDAQ:OSUR) - Aug 31st, 2022 10:29 am
Analysts Just Published A Bright New Outlook For OraSure Technologies, Inc.'s (NASDAQ:OSUR) - Aug 14th, 2022 12:28 pm
OraSure Technologies (OSUR) Reports Break-Even Earnings for Q2 - Aug 9th, 2022 11:25 pm
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year - Aug 9th, 2022 8:05 pm
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET - Aug 2nd, 2022 11:05 am
OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack - Jul 28th, 2022 11:05 am